Logo image of HILS

HILLSTREAM BIOPHARMA INC (HILS) Stock Analyst Earnings Estimates

NASDAQ:HILS - Nasdaq - US4327051011 - Common Stock - Currency: USD

0.2305  +0.01 (+2.76%)

After market: 0.2308 +0 (+0.13%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
HILS revenue by date.HILS revenue by date.
N/AN/AN/AN/A
EBITDA
YoY % growth
HILS ebitda by date.HILS ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
HILS ebit by date.HILS ebit by date.
-1.424M-1.808M
-27.00%		-3.208M
-77.40%		-6.882M
-114.52%		N/A
-9.44%		N/A
36.40%		N/A
-1.00%		N/A
-63.32%
Operating Margin
HILS operating margin by date.HILS operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
HILS eps by date.HILS eps by date.
N/AN/AN/AN/AN/A
35.90%		N/A
70.00%		N/A
33.33%		N/A
-582.60%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 23 Q4 / 23
EPS
Q2Q % growth		-0.06-0.05
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/A
EBIT
Q2Q % growth		-1.734M
18.50%		-1.53M
13.39%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2023
Q2Q % growth		 -0.16 -0.160.001.96%
Q1 2023
Q2Q % growth		 -0.23 -0.11-0.12-104.99%
HILS Yearly EPS VS EstimatesHILS Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% -13.64%
RevenueN/A N/A N/A N/A